CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the use of modified mesenchymal stem cells to deliver magnetic nanoparticles for treating lung cancer. The approach aims to selectively destroy tumor cells while preserving healthy tissue, leveraging the unique properties of stem cells to target cancerous areas effectively.
Lung cancer is the most lethal cancer in the world today.
There are limited options for clinicians when treating patients, with only 10-15% of lung cancer patients surviving their malignancy.
Despite the introduction of new chemotherapies, lung cancer survival is unchanged from thirty years ago.
New ways of treating this disease are needed.
We hypothesise that modified mesenchymal stem cells (MSCs) may be used to deliver magnetic nanoparticles through their engraftment, killing both tumour epith…
The Royal Institution of Great Britain
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
